DONNA GRAVELY: Open Payments
NPI 1205203361 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 56 payments from 8 companies in 2025. Trend: 2023 $78 · 2024 $74 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $213 |
| E.R. Squibb & Sons, L.L.C. | 9 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $164 |
| ABBVIE INC. | 17 | $144 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Alkermes, Inc. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: COBENFY, CAPLYTA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, SPRAVATO, ARISTADA, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
